DK1370284T3 - Bakteriofag-medieret immunisering - Google Patents

Bakteriofag-medieret immunisering

Info

Publication number
DK1370284T3
DK1370284T3 DK02720122.7T DK02720122T DK1370284T3 DK 1370284 T3 DK1370284 T3 DK 1370284T3 DK 02720122 T DK02720122 T DK 02720122T DK 1370284 T3 DK1370284 T3 DK 1370284T3
Authority
DK
Denmark
Prior art keywords
bacteriophage
mediated immunization
immunization
mediated
vaccines
Prior art date
Application number
DK02720122.7T
Other languages
English (en)
Inventor
John Bernard March
Original Assignee
Bigdna Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bigdna Ltd filed Critical Bigdna Ltd
Application granted granted Critical
Publication of DK1370284T3 publication Critical patent/DK1370284T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
DK02720122.7T 2001-03-23 2002-03-25 Bakteriofag-medieret immunisering DK1370284T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0107319.6A GB0107319D0 (en) 2001-03-23 2001-03-23 Bacteriophage-mediated immunisation
PCT/GB2002/001413 WO2002076498A2 (en) 2001-03-23 2002-03-25 Bacteriophage-mediated immunisation

Publications (1)

Publication Number Publication Date
DK1370284T3 true DK1370284T3 (da) 2010-09-27

Family

ID=9911416

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02720122.7T DK1370284T3 (da) 2001-03-23 2002-03-25 Bakteriofag-medieret immunisering

Country Status (13)

Country Link
US (1) US7128916B2 (da)
EP (1) EP1370284B1 (da)
JP (1) JP4653934B2 (da)
AT (1) ATE469655T1 (da)
AU (1) AU2002251192B2 (da)
CA (1) CA2441601C (da)
CY (1) CY1111286T1 (da)
DE (1) DE60236579D1 (da)
DK (1) DK1370284T3 (da)
ES (1) ES2345434T3 (da)
GB (1) GB0107319D0 (da)
PT (1) PT1370284E (da)
WO (1) WO2002076498A2 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222824D0 (en) * 2002-10-02 2002-11-06 Moredun Res Inst Bacteriophage-mediated immunisation II
WO2006095345A2 (en) * 2005-03-08 2006-09-14 Ramot At Tel-Aviv University Ltd. Targeted drug-carrying bacteriophages
CA2673593A1 (en) * 2005-12-23 2007-07-05 Hygea Biopharma, Inc. Immunologically enhanced recombinant vaccines
JP2007204415A (ja) * 2006-02-01 2007-08-16 Tokyo Institute Of Technology ファージ頭殻提示腸管免疫誘導型ワクチン
GB0808780D0 (en) * 2008-05-15 2008-06-18 Big Dna Ltd Fish vaccines
WO2011045573A2 (en) 2009-10-15 2011-04-21 University Court Of The University Of Edinburgh Staphylococcal antigens
WO2011080505A2 (en) 2009-12-28 2011-07-07 Bigdna Ltd Method of growing phage for commercial use
GB201112587D0 (en) 2011-07-22 2011-09-07 Moredun Res Inst Vaccine
EP2970917A2 (en) 2013-03-15 2016-01-20 Altria Client Services LLC Bacteriophage and methods of making and using
WO2016123427A1 (en) 2015-01-29 2016-08-04 Altria Client Services Llc Bacteriophage and methods of using
WO2016123425A1 (en) 2015-01-29 2016-08-04 Altria Client Services Llc Endolysin from bacteriophage against geobacillus and methods of using
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
GB201600075D0 (en) * 2016-01-03 2016-02-17 Glaxosmithkline Biolog Sa Immunogenci composition
US20230218684A1 (en) * 2020-03-30 2023-07-13 North Carolina State University Engineered bacteria for use in vaccine compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736388A (en) 1994-12-30 1998-04-07 Chada; Sunil Bacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cells
WO1998005344A1 (en) * 1996-08-05 1998-02-12 Brigham And Women's Hospital, Inc. Bacteriophage-mediated gene therapy
US6054312A (en) * 1997-08-29 2000-04-25 Selective Genetics, Inc. Receptor-mediated gene delivery using bacteriophage vectors
WO1999055720A1 (en) 1998-04-24 1999-11-04 The Regents Of The University Of California Targeted gene delivery to cells by filamentous bacteriophage
WO2001014579A2 (en) * 1999-08-26 2001-03-01 Vion Pharmaceuticals, Inc. Compositions and methods for delivery of an agent using attenuated salmonella containing phage

Also Published As

Publication number Publication date
CY1111286T1 (el) 2015-08-05
WO2002076498A2 (en) 2002-10-03
CA2441601A1 (en) 2002-10-03
JP2004525931A (ja) 2004-08-26
WO2002076498A3 (en) 2003-08-14
JP4653934B2 (ja) 2011-03-16
US20040121974A1 (en) 2004-06-24
EP1370284A2 (en) 2003-12-17
EP1370284B1 (en) 2010-06-02
GB0107319D0 (en) 2001-05-16
DE60236579D1 (de) 2010-07-15
PT1370284E (pt) 2010-08-03
AU2002251192B2 (en) 2006-11-16
US7128916B2 (en) 2006-10-31
ATE469655T1 (de) 2010-06-15
ES2345434T3 (es) 2010-09-23
CA2441601C (en) 2012-03-13

Similar Documents

Publication Publication Date Title
CY1111286T1 (el) Ανοσοποιηση διαμεσολαβουμενη απο βακτηριοφαγα
ATE433491T1 (de) Oligomerische komplexe von chimären proteinen mit verbessertem immunogenen potential
ATE475675T1 (de) Verwendung prokariotischer pest-ähnlicher peptide zur verstärkung der immunogenität von antigenen
DE60132893D1 (de) Antigene polypeptide
UY28641A1 (es) Anticuerpos
UA107330C2 (uk) Туберкульозний білок rv3616c та його застосування
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
ATE389668T1 (de) Tumorantigen
ZA202300548B (en) Self-amplifying sars-cov-2 rna vaccine
MX2019002178A (es) Peptidos de fusion con antigenos enlazados a fragmentos cortos de cadena invariante (cd74).
NZ535908A (en) HIV regulatory and auxilliary peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
MY144766A (en) Plant virus coat fusion proteins with gdf8 epitopes and vaccines thereof
BRPI0508916A (pt) polipeptìdeos hìbridos imunogênicos antiobesidade e composição de vacina antiobesidade compreendendo-os
DK1368372T3 (da) Peptid med affinitet til det virale gp120-protein samt anvendelse deraf
DK1545594T3 (da) Bakteriofag-medieret immunisering mod Hepatitis
NZ515041A (en) Nucleic acid immunization
ATE387629T1 (de) Gemeinsame epitope von antigenen aus einer multigen-familie
EP1499349A4 (en) RECOMBINANT HYBRID ALLERGENIC CONSTRUCTS WITH REDUCED ALLERGENITY, MAINTAINING THE IMMUNOGENICITY OF NATURAL ALLERGEN
ATE509025T1 (de) ßMIT MHC-KLASSE-I-PEPTIDEPITOPEN KOVALENT VERKN PFTES MEMBRANVERANKERTES BETA2-MIKROGLOBULINß
HUP0203251A2 (hu) Az apolipoprotein B-100 epitópját utánzó peptidek, ezeknek megfelelő konkatemér és módosított peptidek és ezeket tartalmazó vakcinakészítmények
WO2004056316A3 (en) Vaccines against hiv-1 tat protein to generate neutralizing antibodies
ATE525470T1 (de) Antigene epitope des faktors viii, inhibitoren dagegen, und deren verwendungen
GB0220805D0 (en) Peptide monomers and protein structures
ATE355077T1 (de) Verwendung von peptidvektoren zur verbesserung der immunantwort gegen antigene
CO5370685A1 (es) Imunogeno compuesto por un peptido y unna proteina d de haemophilus influenzae que actua como portadora